輸血デバイス市場：製品別、エンドユーザー別-2025-2030年の世界予測

輸血デバイス市場は、2023年に41億2,000万米ドルと評価され、2024年には44億米ドルに達すると予測され、CAGR 7.18％で成長し、2030年には67億米ドルになると予測されています。

輸血デバイスには、血液およびその成分の採取、保存、処理、輸血に使用されるさまざまな機器や器具が含まれます。これらの機器の必要性は、手術中の失血への対応、貧血の治療、外傷の回復支援などにおいて重要な役割を果たすことで強調されています。その用途は、病院、外来手術センター、血液銀行など多岐にわたり、エンドユーザーは、血液の取り扱いと輸血プロセスにおいて正確性、安全性、効率性を求める医療従事者です。輸血デバイス市場は、主に慢性疾患の有病率の上昇、外科手術の増加、献血と輸血の安全性に関する意識の高まりによって牽引されています。安全性を高め、ヒューマンエラーを最小限に抑える自動輸血装置やシステムの開発など、技術の進歩が市場成長に勢いを与えています。しかし、市場の拡大には、感染症のトランスミッションなど輸血に関連するリスクや、機器の調達やメンテナンスに関連する高コストなどの制約があります。さらに、規制上の課題も市場参入のハードルとなっています。こうした課題にもかかわらず、ヘルスケアのインフラが改善しつつある新興国市場や拡大市場ではビジネスチャンスが生まれつつあります。企業は、低資源環境に適した、手頃な価格で携帯可能な使いやすい機器に注力することで、こうした機会を生かすことができます。生体適合性センサー技術や血液分離技術の改良といった分野では、技術革新が促進される態勢が整っています。さらに、医療スタッフ向けのトレーニングイニシアティブに投資することで、これらの機器の導入と最適な使用が改善され、品質と安全性が保証されることでヘルスケア施設に魅力がもたらされる可能性があります。規制機関との協力や厳格な安全プロトコルの遵守は、製品の受容性を高め、課題を軽減することができます。この市場の性質はダイナミックであり、イノベーションは進化するヘルスケアニーズや技術的進歩に左右されることが多く、調査や戦略的成長の余地が大きい競争市場であることを示唆しています。

市場力学：急速に進化する輸血デバイス市場の主要市場インサイトを公開

輸血デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血液関連疾患およびがんの世界的流行
  • 政府の支援による意識向上キャンペーンとスクリーニング血液製剤の需要の高まり
  • 世界の交通事故の増加と手術件数の増加
• 市場抑制要因
  • 輸血デバイスの製造コストの高さ
• 市場機会
  • 技術的に高度なスクリーニング分析装置の入手可能性の急増
  • 輸血デバイスの機能性向上のための継続的調査
• 市場の課題
  • 厳しい承認規制

ポーターの5つの力：輸血デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、輸血デバイス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：輸血デバイス市場における外部からの影響の把握

外部マクロ環境要因は、輸血デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析輸血デバイス市場における競合情勢の把握

輸血デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス輸血デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、輸血デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨輸血デバイス市場における成功への道筋を描く

輸血デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血液関連疾患およびがんの有病率

世界的に

• 政府の支援と検査済み血液製品の需要により啓発キャンペーンが拡大
• 世界中で交通事故件数と手術件数が増加
• 抑制要因
  • 輸血デバイスの生産コストが高い
• 機会
  • 技術的に高度なスクリーニング分析装置の普及の急増
  • 輸血デバイスの機能向上に向けた継続的な調査
• 課題
  • 承認のための厳格な規制方針
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 輸血デバイス市場：製品別

• アフェレーシス装置
• 血液バッグ
• 血液成分分離装置
• 血の混合者
• 消耗品と供給品
• 輸液ポンプ
• 病原体低減システム

第7章 輸血デバイス市場：エンドユーザー別

• 外来手術センター
• 血液銀行
• 病院

第8章 南北アメリカの輸血デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の輸血デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの輸血デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun SE
• Baxter International Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Ecomed Solutions
• EryPharm
• F.Hoffman-La Roche AG
• Fresenius Kabi Malaysia Sdn. Bhd.
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Jiangsu Kangjin Medical Instrument Co.,Ltd.
• Kawasumi Laboratories, Inc.
• Macopharma
• Nipro Medical Corporation
• Ortho-Clinical Diagnostics, Inc.
• Quotient Suisse SA
• Sarstedt AG & Co. KG
• Siemens AG
• SURU INTERNATIONAL PVT. LTD.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. BLOOD TRANSFUSION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD TRANSFUSION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD MIXER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONSUMABLES & SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Transfusion Devices Market was valued at USD 4.12 billion in 2023, expected to reach USD 4.40 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 6.70 billion by 2030.

Blood transfusion devices encompass a range of equipment and instruments used to collect, store, process, and transfuse blood and its components. The necessity of these devices is underscored by their critical role in addressing blood loss during surgeries, treating anemia, and supporting traumatic injury recovery. Their applications stretch across hospitals, ambulatory surgical centers, and blood banks, with end-users being medical professionals who demand precision, safety, and efficiency in blood handling and transfusion processes. The market for blood transfusion devices is primarily driven by the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness regarding blood donation and transfusion safety. Technological advancements, such as the development of automated transfusion devices and systems that enhance safety and minimize human error, add momentum to market growth. However, market expansion faces limitations such as the risks associated with blood transfusion, including the transmission of infectious diseases, and the high costs related to device procurement and maintenance. Furthermore, regulatory challenges pose hurdles for market players. Despite these challenges, opportunities are emerging in developing and expanding markets where healthcare infrastructure is improving. Companies can capitalize on these opportunities by focusing on affordable, portable, and easy-to-use devices that suit low-resource settings. Innovation is poised to thrive in areas like biocompatible sensor technology and improved blood separation techniques. Moreover, investing in training initiatives for medical staff could improve the adoption and optimized use of these devices, enticing healthcare facilities with assurances of quality and safety. Collaboration with regulatory bodies and adherence to strict safety protocols can enhance product acceptance and mitigate challenges. The nature of this market is dynamic, with innovations often steered by evolving healthcare needs and technological advancements, suggesting a competitive landscape with robust scope for research and strategic growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Transfusion Devices Market

The Blood Transfusion Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of blood-related disorders and cancer globally
  • Growing awareness campaigns with government support and demand for screened blood products
  • Rising cases of road accidents and increase in number of surgeries worldwide
• Market Restraints
  • High cost of production of blood transfusion devices
• Market Opportunities
  • Surge in availability of technologically advanced screening analyzers
  • Ongoing research to improve the functionality of blood transfusion devices
• Market Challenges
  • Strict regulatory policies for approval

Porter's Five Forces: A Strategic Tool for Navigating the Blood Transfusion Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Transfusion Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Transfusion Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Transfusion Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Transfusion Devices Market

A detailed market share analysis in the Blood Transfusion Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Transfusion Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Transfusion Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Transfusion Devices Market

A strategic analysis of the Blood Transfusion Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Transfusion Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Ecomed Solutions, EryPharm, F.Hoffman-La Roche AG, Fresenius Kabi Malaysia Sdn. Bhd., Fresenius SE & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Jiangsu Kangjin Medical Instrument Co.,Ltd., Kawasumi Laboratories, Inc., Macopharma, Nipro Medical Corporation, Ortho-Clinical Diagnostics, Inc., Quotient Suisse SA, Sarstedt AG & Co. KG, Siemens AG, SURU INTERNATIONAL PVT. LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Transfusion Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Apheresis Device, Blood Bag, Blood Component Separator, Blood Mixer, Consumables & Supplies, Infusion Pumps, and Pathogen Reduction System.
• Based on End-user, market is studied across Ambulatory Surgical Centres, Blood Bank, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of blood-related disorders and cancer

globally

• 5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
• 5.1.1.3. Rising cases of road accidents and increase in number of surgeries worldwide
• 5.1.2. Restraints
  • 5.1.2.1. High cost of production of blood transfusion devices
• 5.1.3. Opportunities
  • 5.1.3.1. Surge in availability of technologically advanced screening analyzers
  • 5.1.3.2. Ongoing research to improve the functionality of blood transfusion devices
• 5.1.4. Challenges
  • 5.1.4.1. Strict regulatory policies for approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Transfusion Devices Market, by Product

• 6.1. Introduction
• 6.2. Apheresis Device
• 6.3. Blood Bag
• 6.4. Blood Component Separator
• 6.5. Blood Mixer
• 6.6. Consumables & Supplies
• 6.7. Infusion Pumps
• 6.8. Pathogen Reduction System

7. Blood Transfusion Devices Market, by End-user

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centres
• 7.3. Blood Bank
• 7.4. Hospital

8. Americas Blood Transfusion Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Blood Transfusion Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Blood Transfusion Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun SE
• 3. Baxter International Inc.
• 4. Becton Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. bioMerieux SA
• 7. Ecomed Solutions
• 8. EryPharm
• 9. F.Hoffman-La Roche AG
• 10. Fresenius Kabi Malaysia Sdn. Bhd.
• 11. Fresenius SE & Co. KGaA
• 12. Grifols, S.A.
• 13. Haemonetics Corporation
• 14. Jiangsu Kangjin Medical Instrument Co.,Ltd.
• 15. Kawasumi Laboratories, Inc.
• 16. Macopharma
• 17. Nipro Medical Corporation
• 18. Ortho-Clinical Diagnostics, Inc.
• 19. Quotient Suisse SA
• 20. Sarstedt AG & Co. KG
• 21. Siemens AG
• 22. SURU INTERNATIONAL PVT. LTD.
• 23. Terumo Corporation